LENSAR Inc
NASDAQ:LNSR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.17
7.47
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one LNSR stock under the Base Case scenario is 8.59 USD. Compared to the current market price of 7.38 USD, LENSAR Inc is Undervalued by 14%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
LENSAR Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for LNSR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
LENSAR Inc
Balance Sheet Decomposition
LENSAR Inc
Current Assets | 40.2m |
Cash & Short-Term Investments | 14.2m |
Receivables | 6.2m |
Other Current Assets | 19.8m |
Non-Current Assets | 21.2m |
Long-Term Investments | 1.2m |
PP&E | 10.3m |
Intangibles | 6.6m |
Other Non-Current Assets | 3m |
Current Liabilities | 10.4m |
Accounts Payable | 4.1m |
Accrued Liabilities | 4.8m |
Other Current Liabilities | 1.4m |
Non-Current Liabilities | 13.6m |
Other Non-Current Liabilities | 13.6m |
Earnings Waterfall
LENSAR Inc
Revenue
|
45.1m
USD
|
Cost of Revenue
|
-22.6m
USD
|
Gross Profit
|
22.5m
USD
|
Operating Expenses
|
-31.9m
USD
|
Operating Income
|
-9.4m
USD
|
Other Expenses
|
-3.2m
USD
|
Net Income
|
-12.6m
USD
|
Free Cash Flow Analysis
LENSAR Inc
USD | |
Free Cash Flow | USD |
LNSR Profitability Score
Profitability Due Diligence
LENSAR Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
LENSAR Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
LNSR Solvency Score
Solvency Due Diligence
LENSAR Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
LENSAR Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LNSR Price Targets Summary
LENSAR Inc
According to Wall Street analysts, the average 1-year price target for LNSR is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
Dividends
Current shareholder yield for LNSR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
LNSR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 110 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company has developed the LENSAR Laser System to provide an alternative laser cataract treatment tool that allows the surgeon to better address astigmatism and improve visual outcomes. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The company is also developing an integrated cataract treatment system, ALLY, which is designed to combine its existing femtosecond laser technology with phacoemulsification system into a single unit and allow surgeons to perform each of the critical steps in a cataract procedure in a single operating room using this device.
Contact
IPO
Employees
Officers
The intrinsic value of one LNSR stock under the Base Case scenario is 8.59 USD.
Compared to the current market price of 7.38 USD, LENSAR Inc is Undervalued by 14%.